Stay updated on FRα Clinical Trial: Mirvetuximab vs. Chemo
Sign up to get notified when there's something new on the FRα Clinical Trial: Mirvetuximab vs. Chemo page.

Latest updates to the FRα Clinical Trial: Mirvetuximab vs. Chemo page
- Check5 days agoChange DetectedNew UI elements are introduced: a 'Show glossary' option, and additional metadata fields 'Last Update Submitted that Met QC Criteria' and 'Revision: v3.4.0' appear on the page. The previous labels 'Last Update Submitted that met QC Criteria', 'No FEAR Act data', and the earlier revision 'v3.3.4' are removed.SummaryDifference0.1%

- Check12 days agoNo Change Detected
- Check20 days agoChange Detected- Revision metadata updated: added Revision: v3.3.4 and removed Revision: v3.3.3.SummaryDifference0.0%

- Check41 days agoChange DetectedLocations section replaced with a comprehensive new list of study sites across the US, Canada, and Europe. Old per-state location groupings were removed, and the page revision was updated to v3.3.3.SummaryDifference2%

- Check70 days agoChange DetectedThe Publications section text now states that publications are automatically filled from PubMed, and the revision labels show v3.3.2 (replacing v3.2.0). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check77 days agoChange DetectedNotice about government funding status on the NIH Clinical Center page is removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check91 days agoChange DetectedThe Locations section was updated to reflect changes in participating study sites. These updates affect where patients can enroll and where results may apply.SummaryDifference0.2%

Stay in the know with updates to FRα Clinical Trial: Mirvetuximab vs. Chemo
Enter your email address, and we'll notify you when there's something new on the FRα Clinical Trial: Mirvetuximab vs. Chemo page.